HYPOGLYCAEMIC EPISODES EVALUATED BY CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES AND DIALYSIS-DEPENDENT END-STAGE RENAL DISEASE RANDOMISED TO 12-WEEK LIRAGLUTIDE OR PLACEBO TREATMENT

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberSP426
JournalNephrology Dialysis Transplantation
Volume33
Issue numbersuppl_1
Pages (from-to)492-492
ISSN0931-0509
DOIs
Publication statusPublished - May 2018

ID: 199952451